SCHEMBL3392541

SCHEMBL3392541

CC1C(C)(C)C1(C)C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9639872 0.80
Taurine SCHEMBL4633120 0.77 LMNA (0.48)
SCHEMBL1376057 0.73 MAPK1 (0.44)
SCHEMBL9628774 0.71 APLNR (0.31)
Hydrochloric Acid SCHEMBL11238901 0.71 MAPK1 (0.42)
SCHEMBL3391084 0.71 PKM (0.35)
SCHEMBL10797089 0.69
SCHEMBL5127284 0.69
SCHEMBL10017926 0.67
Bicarbonate SCHEMBL9628771 0.67 MAPK1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487787-B1 DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS OF N-HYDROXYALKYL TETRAMETHYLCYCLOPROPANE-CARBOXAMIDE, HAVING ANTI-EPILEPTIC AND METHOD FOR THEIR PREPARATION YISSUM RES DEV CO (IL) 2010-12-22 EP disclosed
EP-2176219-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS Abbott Laboratories (US) 2010-04-21 EP disclosed
WO-2009009550-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2009-01-15 WO disclosed
EP-1603891-B1 NEW AMIDE DERIVATIVES OF 2,2,3,3-TETRAMETHYLCYCLOPROPANE CARBOXYLIC ACID YISSUM RES DEV CO (IL) 2008-05-28 EP disclosed
US-7232929-B2 Amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2007-06-19 US disclosed
US-20060148861-A1 Amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid YISSUM RESEARCH DEVELOPEMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2006-07-06 US disclosed
EP-1603891-A1 NEW AMIDE DERIVATIVES OF 2,2,3,3-TETRAMETHYLCYCLOPROPANE CARBOXYLIC ACID YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2005-12-14 EP disclosed
US-6960687-B2 Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epiletic, neurological, and CNS activity, and method for their preparation YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2005-11-01 US disclosed
US-20050131069-A1 Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epiletic, neurological, and cns activity, and method for their preparation YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW (IL) 2005-06-16 US disclosed
EP-1487787-A1 DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS OF N-HYDROXYALKYL TETRAMETHYLCYCLOPROPANE-CARBOXAMIDE, HAVING ANTI-EPILEPTIC, NEUROLOGICAL, AND CNS ACTIVITY, AND METHOD FOR THEIR PREPARATION Yissum Research Development Company of the Hebrew University of Jerusalem (IL) 2004-12-22 EP disclosed
WO-2004076432-A1 NEW AMIDE DERIVATIVES OF 2,2,3,3-TETRAMETHYLCYCLOPROPANE CARBOXYLIC ACID YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-09-10 WO disclosed
WO-2003064374-A1 DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS OF N-HYDROXYALKYL TETRAMETHYLCYCLOPROPANE-CARBOXAMIDE, HAVING ANTI-EPILEPTIC, NEUROLOGICAL, AND CNS ACTIVITY, AND METHOD FOR THEIR PREPARATION YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2003-08-07 WO disclosed
WO-2003048181-A1 17.ALPHA. -CYCLIC ESTERS OF 16-METHYLPREGNAN-3,20-DIONE AS ANTI-INFLAMMATORY AGENTS GLAXO GROUP LIMITED (GB) 2003-06-12 WO disclosed
US-4699922-A PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 1987-10-13 US disclosed
US-4318922-A INSECTICIDES, ACARICIDES BAYER AKTIENGESELLSCHAFT (DE) 1982-03-09 US disclosed